BrainsWay Ltd. (TLV:BWAY)

Market Cap	757.07M
Revenue (ttm)	161.81M
Net Income (ttm)	14.58M
Shares Out	37.80M
EPS (ttm)	0.29
PE Ratio	67.96
Forward PE	40.57
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,443
Average Volume	45,623
Open	2,002.00
Previous Close	2,002.00
Day's Range	1,986.00 - 2,011.00
52-Week Range	1,159.00 - 2,359.00
Beta	0.32
RSI	44.72
Earnings Date	Aug 13, 2025

About Accolade

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases. The company serves do...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 120
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: BWAY